(Q44086437)

29 November 2017

title

Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma (English)

1 reference

29 November 2017

Hua Zhang

1

1 reference

29 November 2017

Jun Liu

2

1 reference

29 November 2017

Dongsheng Yue

3

1 reference

29 November 2017

Liuwei Gao

4

1 reference

29 November 2017

Daowei Wang

5

1 reference

29 November 2017

Hongdian Zhang

6

1 reference

29 November 2017

Changli Wang

7

1 reference

29 November 2017

language of work or name

English

0 references

publication date

13 July 2013

1 reference

Journal of Clinical Pathology

29 November 2017

published in

1 reference

29 November 2017

volume

66

1 reference

29 November 2017

issue

11

1 reference

29 November 2017

page(s)

937-945

1 reference

China wrestles with lung cancer

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Pemetrexed in the treatment of advanced non-squamous lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Epithelial-mesenchymal transition in cancer development and its clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Vimentin expression predicts the occurrence of metastases in non small cell lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Expression of Frat1 correlates with expression of β-catenin and is associated with a poor clinical outcome in human SCC and AC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Biomarkers for epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

S100A4 and metastasis: a small actor playing many roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Expression of protein S100A4 is a predictor of recurrence in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

Beta-catenin expression is prognostic of improved non–small cell lung cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2013-201467

10.1136/JCLINPATH-2013-201467

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference